Cargando…
Cardiac Amyloidosis Treatment
Cardiac amyloidosis (CA) is a restrictive cardiomyopathy with a traditionally poor prognosis. Until recently, CA treatment options were limited and consisted predominantly of managing symptoms and disease-related complications. However, the last decade has seen significant advances in disease-modify...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Houston Methodist DeBakey Heart & Vascular Center
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932359/ https://www.ncbi.nlm.nih.gov/pubmed/35414852 http://dx.doi.org/10.14797/mdcvj.1050 |